EPISODE · Dec 14, 2022 · 39 MIN
Ep 12: Chris Gibson on Building a Platform Biotech and The Future of R&D
from Vital Signs with Jacob Effron and Nikhil Krishnan · host Redpoint Ventures
Jacob sits down with Chris Gibson, the co-founder and CEO of Recursion, to discuss how Recursion predicted drugs that would be effective for COVID, his take on different techbio business models, what pharma R&D will look like in 25 years and more.
What this episode covers
Jacob sits down with Chris Gibson, the co-founder and CEO of Recursion, to discuss how Recursion predicted drugs that would be effective for COVID, his take on different techbio business models, what pharma R&D will look like in 25 years and more.
NOW PLAYING
Ep 12: Chris Gibson on Building a Platform Biotech and The Future of R&D
No transcript for this episode yet
Similar Episodes
Mar 26, 2026 ·1m
Mar 19, 2026 ·34m
Feb 18, 2026 ·11m
Feb 11, 2026 ·45m